The so-called 'King Kong' of weight-loss drugs can cause side effects like nausea, but may also help users build healthy ...

Expert advice on what you need to know - Mounjaro has been approved for both type 2 diabetes and weight loss, but access will ...

Key Takeaways One shot a month of an experimental drug yielded promising results in a new clinical trialThe drug, called ...

NICE says that in some exceptional circumstances the BMI requirements can drop down to 30, and people from some ethnic ...

A WOMAN has revealed that she has lost over 4st using weight loss injections. Kathryn Elizabeth, from the UK, took to social ...

Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...

Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be ...

The Weight Loss Revolution— that’s released on Wednesday provides a detailed insight into these weight management drugs and ...

With obesity and Type 2 diabetes on the rise, India is emerging as a key battleground for global drugmakers developing next-generation therapies targeting metabolic disorders.

Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose up to 20 per cent body weight. But is it safe? Experts answer.

Only a small number of people will be eligible for weight loss injections through the NHS, a Nottinghamshire doctor has said. Prescriptions for Mounjaro jabs were made available at GP surgeries in ...

A Cornwall GP surgery is warning patients that the new NHS weight loss jab, Mounjaro, will only be prescribed under exceptionally strict criteria, as the national rollout began this week. From Monday, ...